Form 4 for AORT ARTIVION, INC.
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0000784199-24-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-22 | 2024-02-20 | AORT | Mackin James P | Pres, CEO | S - Sale+OE | $18.85 | -72.1K | 541.8K | -12% | -$1.36M |
| D | 2024-02-22 | 2024-02-20 | AORT | Mackin James P | Pres, CEO | M - OptEx | $16.30 | +59.2K | 611.1K | +11% | +$965.4K |
| D | 2024-02-22 | 2024-02-20 | AORT | Mackin James P | Pres, CEO | M - OptEx | $0.00 | -59.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | S | D | 59,225 | $18.85 | 551,880 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2023. (F2) Reflects weighted average price. Range of prices were between $18.05 to $19.295. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-02-20 | M | A | 59,225 | $16.30 | 611,105 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2023. |
| 3 | Common | Common Stock | 2024-02-20 | S | D | 2,756 | $18.87 | 539,036 | D | — | — | (F4) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |
| 4 | Common | Common Stock | 2024-02-20 | S | D | 10,088 | $18.87 | 541,792 | D | — | — | (F3) These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |
| 5 | Derivative | Stock Option(Right to Buy) | 2024-02-20 | M | D | 59,225 | $0.00 | 0 | D | $16.30 · 2018-02-21 to 2024-02-21 | 59,225 Common Stock | (F5) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018. |